Cart
sales@molnova.com
Home - Products - Others - Other Targets - Indole-3-glyoxylamide

Indole-3-glyoxylamide

CAS No. 5548-10-7

Indole-3-glyoxylamide( —— )

Catalog No. M37816 CAS No. 5548-10-7

Indole-3-glyoxylamide (3-Indoleglyoxamide) is a marine derived natural products found in Spongosorites sp.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 296 Get Quote
5MG 426 Get Quote
10MG 625 Get Quote
25MG 908 Get Quote
50MG 1270 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Indole-3-glyoxylamide
  • Note
    Research use only, not for human use.
  • Brief Description
    Indole-3-glyoxylamide (3-Indoleglyoxamide) is a marine derived natural products found in Spongosorites sp.
  • Description
    Indole-3-glyoxylamide (3-Indoleglyoxamide) is a marine derived natural products found in Spongosorites sp.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    5548-10-7
  • Formula Weight
    188.18
  • Molecular Formula
    C10H8N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    NC(=O)C(=O)c1c[nH]c2ccccc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • IRG1-IN-1

    IRG1-IN-1, an itaconic acid derivative, inhibits Immune Response Gene 1 (IRG1) activity and is suitable for cancer, inflammation, and autoimmune disease research.

  • NCGC00135472

    NCGC00135472 (DRV1 (GPR32) agonist C2A) is a human Resolvin DI receptor DRV1 agonist with pro-catabolic properties that activates the human soluble protein D1 receptor DRV1/GPR32 receptor in beta-blocker and cAMP assays with EC50s of 0.37 uM and 0.05 uM, respectively.

  • Sabatolimab

    Sabatolimab (MBG453), a humanized IgG4 (S228P) antibody targeting TIM-3, is a potent inhibitory receptor that regulates adaptive and innate immune responses.

Sign In Join Free